METHIONINE UPTAKE BY TUMOR-TISSUE - A MICROAUTORADIOGRAPHIC COMPARISON WITH FDG

被引:0
|
作者
KUBOTA, R
KUBOTA, K
YAMADA, S
TADA, M
TAKAHASHI, T
IWATA, R
TAMAHASHI, N
机构
[1] TOHOKU UNIV,INST AGING DEV & CANC,DEPT NUCL MED,SENDAI,MIYAGI,JAPAN
[2] TOHOKU UNIV,INST AGING DEV & CANC,DEPT RADIOL & PHARMACOL,SENDAI,MIYAGI,JAPAN
[3] TOHOKU UNIV,CTR CYCLOTRON & RADIOISOTOPE,SENDAI,MIYAGI,JAPAN
[4] CLUSTERECORE INST BIOL,SENDAI,MIYAGI,JAPAN
关键词
CANCER IMAGING; METHIONINE UPTAKE; FDG; MALIGNANCY;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
L-methyl-C-11-methionine (C-11-Met) and 2-deoxy-2-F-18-fluoro-D-glucose (F-18-FDG) are used for tumor diagnosis and treatment evaluation by PET. In order to examine the role of these tracers in cancer imaging, intratumoral properties of C-14-Met were studied and compared to those of F-18-FDG. Methods: The distribution of C-14-Met in various cellular elements of two different mouse malignant tumor tissues, MH134 and FM3A, was analyzed serially using microautoradiography within a period of 120 min after injection of the tracer. Results: Carbon-14-Met and F-18-FDG showed different distributions in tumor tissue. Carbon-14-Met uptake by the tumor was mostly by viable cancer cells. The uptake by macrophages and other cellular components was low. The uptake was higher in the highly proliferative tumor but did not reflect protein synthesis. The rapid and slow growing tumors demonstrated that C-14-Met uptake ratio was lower than that of F-18-FDG, reflecting de novo DNA synthesis ratio. Conclusion: Carbon-14-Met uptake represents the presence of viable cancer cells. Carbon-11-Met may be suitable for treatment evaluation of individual tumors but not growth rates of different tumors. Flourine-18-FDG reflects tumor-host immune system reaction and is an excellent tool for pretreatment evaluation of tumors and determination of tumor proliferative activity.
引用
收藏
页码:484 / 492
页数:9
相关论文
共 50 条
  • [31] ISOLATION AND EXPANSION OF LYMPHOCYTES FROM GASTROINTESTINAL TUMOR-TISSUE
    SOMERS, SS
    GUILLOU, PJ
    [J]. SURGICAL ONCOLOGY-OXFORD, 1993, 2 (05): : 283 - 291
  • [32] BETAGLUCURONIDASE ACTIVITY IN SERUM AND TUMOR-TISSUE IN UROTHELIAL CARCINOMA
    BICKEBOLLER, R
    UNKELBACH, U
    SEIFFERT, U
    JONAS, D
    [J]. MEDIZINISCHE WELT, 1992, 43 (05): : 426 - 427
  • [33] DISAGGREGATION OF TUMOR-TISSUE AND PROGNOSIS IN STOMACH-CANCER
    LOBANOV, SL
    SHIROKOV, VA
    [J]. VOPROSY ONKOLOGII, 1985, 31 (11) : 30 - 32
  • [34] IN-VITRO ASSESSMENT OF FDG, METHIONINE AND THYMIDINE UPTAKE
    FRANK, A
    GUPTA, N
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (12) : 2278 - 2279
  • [35] THE CONSEQUENCES OF DOXORUBICIN QUINONE REDUCTION INVIVO IN TUMOR-TISSUE
    CUMMINGS, J
    WILLMOTT, N
    HOEY, BM
    MARLEY, ES
    SMYTH, JF
    [J]. BIOCHEMICAL PHARMACOLOGY, 1992, 44 (11) : 2165 - 2174
  • [36] MEASUREMENT OF THE GRADE OF VASCULARIZATION IN HISTOLOGICAL TUMOR-TISSUE SECTIONS
    MLYNEK, ML
    VANBEUNIGEN, D
    LEDER, LD
    STREFFER, C
    [J]. BRITISH JOURNAL OF CANCER, 1985, 52 (06) : 945 - 948
  • [37] ANALYSIS OF STEROIDS FROM NORMAL AND TUMOR-TISSUE BY HPLC
    KESSLER, MJ
    [J]. CLINICA CHIMICA ACTA, 1982, 125 (01) : 21 - 30
  • [38] A SEARCH FOR D-AMINO ACIDS IN TUMOR-TISSUE
    STROUD, ED
    SMITH, GG
    [J]. BIOCHEMICAL MEDICINE, 1984, 31 (02): : 254 - 256
  • [39] INHIBIN AND ACTIVIN ARE DEMONSTRABLE BY IMMUNOHISTOCHEMISTRY IN OVARIAN TUMOR-TISSUE
    GURUSINGHE, CJ
    HEALY, DL
    JOBLING, T
    MAMERS, P
    BURGER, HG
    [J]. GYNECOLOGIC ONCOLOGY, 1995, 57 (01) : 27 - 32
  • [40] ASSAY OF SUPEROXIDE-DISMUTASE ACTIVITY IN TUMOR-TISSUE
    OBERLEY, LW
    SPITZ, DR
    [J]. METHODS IN ENZYMOLOGY, 1984, 105 : 457 - 464